No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1316 |
4. Check minimum number of eventsNone |
1316 |
5. Include endpointsNone |
1316 |
6. Filter based on genotype QC (FinnGen only) |
1182 |
Control definitions (FinnGen only)
- Control exclude
- H7_CONJUNCTIVA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H10
- Name in latin
- Conjunctivitis chronica
Similar endpoints
↥List of similar endpoints to
Chronic conjunctivitis
based on the number of shared cases.
Similar with more cases:
- Conjunctivitis
- Disorders of conjunctiva
- Diseases of the eye and adnexa
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8152 | 4892 | 3233 |
| Only index persons | 7374 | 4515 | 2859 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.14 | 0.09 |
| Only index persons | 0.14 | 0.17 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 38.99 | 44.07 | 31.30 |
| Only index persons | 40.61 | 44.61 | 34.30 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1182 | 831 | 351 |
| Unadjusted period prevalence (%) | 0.26 | 0.30 | 0.16 |
| Median age at first event (years) | 48.98 | 48.60 | 49.87 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1223
- Matched controls
- 12230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S01GX01
ATC
cromoglicic acid; ophthalmic
18.5
307.7
780
1065
H10.4
ICD-10 Finland
Chronic conjunctivitis
4503599627370496.0
307.7
1205
6
H04.10
ICD-10 Finland
Dry eye syndrome
11.0
307.7
517
761
S01GX05
ATC
lodoxamide; ophthalmic
153.9
307.7
256
21
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
6.9
217.7
906
3595
S01GX09
ATC
olopatadine; ophthalmic
24.4
216.0
158
74
H10.5
ICD-10 Finland
Blepharoconjunctivitis
21.8
174.7
133
68
S01GX08
ATC
ketotifen; ophthalmic
13.3
163.1
163
140
S01GX02
ATC
levocabastine; ophthalmic
10.7
154.8
181
196
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
4.5
149.8
648
2443
XQ800
NOMESCO Finland
Prick test
6.7
140.2
253
455
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
17.3
131.6
111
70
H01.0
ICD-10 Finland
Blepharitis
6.2
115.2
223
426
S01GX04
ATC
nedocromil; ophthalmic
23.7
112.7
82
37
S01XA18
ATC
ciclosporin; ophthalmic
36.5
109.9
69
20
S01GX06
ATC
emedastine; ophthalmic
31.2
103.4
68
23
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
6.1
101.6
194
364
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
6.3
99.4
183
331
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
25.7
96.6
68
28
R06AX27
ATC
desloratadine; oral
3.1
77.6
529
2436
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
7.2
75.4
117
176
R06AE07
ATC
cetirizine; oral
2.8
68.5
703
3955
S01AA01
ATC
chloramphenicol; ophthalmic
5.8
68.4
133
251
L20.0
ICD-10 Finland
Besnier prurigo
4.4
67.9
192
498
R06AX22
ATC
ebastine; oral
3.3
64.6
315
1178
E0000UV, ,
ATC
2.7
61.5
652
3664
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.9
57.7
195
573
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
4.8
57.0
138
315
D11AH01
ATC
tacrolimus; topical
17.7
56.0
46
27
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.7
55.0
202
627
S01KA02
ATC
hypromellose; ophthalmic
10.6
55.0
61
60
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
10.5
54.4
61
61
R01AD08
ATC
fluticasone; nasal
2.6
53.1
449
2224
R03DC03
ATC
montelukast; oral
2.8
48.7
298
1247
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
3.9
48.7
155
435
S01BC03
ATC
diclofenac; ophthalmic
7.9
48.3
68
91
H02AB07
ATC
prednisone; oral
3.1
48.2
237
878
Z2221
NOMESCO Finland
Medical doctor
2.5
47.6
431
2184
E000001, ,
ATC
2.7
46.0
327
1472
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.9
45.8
106
232
J31.0
ICD-10 Finland
Chronic rhinitis
3.5
45.8
179
576
R06AX13
ATC
loratadine; oral
2.9
44.5
259
1050
J30.3
ICD-10 Finland
Other allergic rhinitis
5.1
44.2
97
203
S01AD03
ATC
aciclovir; ophthalmic
5.5
43.6
87
167
F29
ICPC
Eye symptom/complaint other
3.1
42.6
204
741
D07AB08
ATC
desonide; topical
3.2
42.0
192
678
R06AE09
ATC
levocetirizine; oral
2.8
41.4
244
993
S01BA01
ATC
dexamethasone; ophthalmic
5.7
41.2
79
146
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
9.6
40.3
48
52
H16.2
ICD-10 Finland
Keratoconjunctivitis
13.5
40.1
38
29
H16.9
ICD-10 Finland
Keratitis, unspecified
7.3
39.7
59
84
Z3231
NOMESCO Finland
Registered nurse
2.3
38.3
409
2192
H02AB06
ATC
prednisolone; systemic
2.2
38.0
638
4094
S01AX11
ATC
[U] ofloxacin
5.3
37.4
77
152
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
37.1
526
3152
R01AD09
ATC
mometasone; nasal
2.1
36.3
646
4215
R03AC02
ATC
salbutamol; inhalant
2.2
35.7
769
5383
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
35.5
291
1383
XQ802
NOMESCO Finland
Epicutan test
4.4
34.9
91
219
D07AA02
ATC
hydrocortisone; topical
2.6
33.7
236
1039
R03AC03
ATC
terbutaline; inhalant
2.6
33.7
220
936
R03BA02
ATC
budesonide; inhalant
2.4
33.5
281
1346
R06AX26
ATC
fexofenadine; oral
3.4
33.5
131
419
H57.1
ICD-10 Finland
Ocular pain
4.4
32.2
84
202
H10
ICD-10 Finland
Conjunctivitis
3.1
32.0
144
501
C01CA24
ATC
epinephrine; parenteral
3.4
31.8
124
395
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
31.4
288
1431
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.3
29.8
280
1402
XCK10
NOMESCO Finland
Photography of fundus of eye
2.9
29.2
148
550
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.8
29.0
163
640
R4110
NOMESCO Finland
Physiotherapy
2.1
28.7
390
2253
R01AD58
ATC
fluticasone, combinations; nasal
2.1
28.5
364
2053
Z51.6
ICD-10 Finland
Desensitization to allergens
10.6
28.1
31
30
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
5.7
27.9
53
97
R01AD05
ATC
budesonide; nasal
3.1
27.8
125
434
J01AA02
ATC
doxycycline; systemic
2.2
27.0
962
7697
J45
ICD-10 Finland
Asthma
2.6
26.6
167
693
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.7
26.5
154
614
Z3226
NOMESCO Finland
Physiotherapist
2.2
26.5
266
1362
J05AB11
ATC
valaciclovir; oral
2.3
26.3
226
1084
E000002, ,
ATC
2.6
26.1
168
705
XCH00
NOMESCO Finland
Eye pressure measurement
3.7
26.0
84
236
D07AC13
ATC
mometasone; topical
2.0
25.6
384
2283
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
25.4
311
1716
S01BA04
ATC
prednisolone; ophthalmic
5.9
25.2
46
81
XCK00
NOMESCO Finland
Perimetry
3.4
25.2
96
301
H16.0
ICD-10 Finland
Corneal ulcer
3.4
25.0
92
282
J01FA10
ATC
azithromycin; systemic
1.9
24.4
765
5746
R03AK07
ATC
formoterol and budesonide; inhalant
2.1
24.4
301
1664
A02BC05
ATC
esomeprazole; systemic
1.9
23.9
518
3459
R01AD12
ATC
fluticasone furoate; nasal
1.9
23.7
439
2786
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
23.2
397
2454
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
22.9
695
5124
J45.1
ICD-10 Finland
Nonallergic asthma
2.8
22.8
124
477
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
3.6
22.8
79
233
CFA20
NOMESCO Finland
Biopsy of conjunctiva
40.9
22.7
28
7
J02AC01
ATC
fluconazole; systemic
1.8
22.7
530
3608
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
22.6
82
249
G44.2
ICD-10 Finland
Tension-type headache
2.2
22.6
209
1030
D11AX14
ATC
[U] tacrolimus
27.9
22.3
30
11
F03
ICPC
Eye discharge
2.8
21.9
120
463
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.7
21.8
126
500
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
21.5
347
2095
J01FA06
ATC
roxithromycin; oral
1.8
21.4
503
3412
D07AC01
ATC
betamethasone; topical
1.8
21.3
458
3025
F02
ICPC
Red eye
3.3
21.1
82
260
N03AX16
ATC
[U] pregabalin
2.0
21.1
295
1695
ZXD20
NOMESCO Finland
Day surgery
2.3
20.9
187
906
N02AX02
ATC
tramadol; systemic, rectal
1.8
20.8
520
3586
H02AB04
ATC
methylprednisolone; systemic
2.2
20.6
195
967
L20
ICD-10 Finland
Atopic dermatitis
4.0
20.5
60
157
D07AD01
ATC
clobetasol; topical
2.1
20.3
231
1230
J01DB01
ATC
cefalexin; oral
2.1
20.2
1027
8726
J30.0
ICD-10 Finland
Vasomotor rhinitis
4.3
20.1
52
124
R42
ICD-10 Finland
Dizziness and giddiness
1.9
20.1
296
1727
ZXA05
NOMESCO Finland
Left side
1.9
20.0
300
1760
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.0
20.0
43
88
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
19.9
575
4115
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.2
19.9
189
939
L71.8
ICD-10 Finland
Other rosacea
5.3
19.7
40
78
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
106.8
19.6
21
*
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
5.6
19.4
37
68
M25.5
ICD-10 Finland
Pain in joint
1.8
19.4
449
3012
ZXE00
NOMESCO Finland
One hour or less
1.8
19.4
489
3362
T78.4
ICD-10 Finland
Allergy, unspecified
3.2
19.4
78
253
ZXA10
NOMESCO Finland
Bilateral
2.0
19.4
239
1310
S01BC05
ATC
ketorolac; ophthalmic
3.9
19.3
58
155
R01AD01
ATC
beclometasone; nasal
2.1
19.2
205
1064
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
26.5
19.2
26
10
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
55.9
19.0
22
*
S01ED01
ATC
timolol; ophthalmic
4.2
18.9
51
126
3721A
ICD-9 Finland
Disorders of conjunctiva, Chronic conjunctivitis
+∞
18.8
18
*
N05BB01
ATC
hydroxyzine; systemic
2.8
18.8
96
357
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
18.7
474
3255
ZXA00
NOMESCO Finland
Right side
1.9
18.5
323
1985
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
18.5
442
2983
R03BA05
ATC
fluticasone; inhalant
2.0
18.4
250
1415
WX002
NOMESCO Finland
Sedation and analgesia
2.0
18.2
242
1358
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
18.2
361
2304
M79.6
ICD-10 Finland
Pain in limb
1.7
18.2
563
4075
A02BC02
ATC
pantoprazole; systemic
1.8
18.2
827
6647
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
17.9
119
505
M03BX02
ATC
tizanidine; oral
1.7
17.9
762
6000
H11.3
ICD-10 Finland
Conjunctival haemorrhage
3.7
17.7
57
160
Z71.8
ICD-10 Finland
Other specified counselling
1.7
17.6
450
3085
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
17.6
131
586
J01AA04
ATC
lymecycline; systemic
2.1
17.4
179
914
H10.2
ICD-10 Finland
Other acute conjunctivitis
5.7
17.3
32
57
L71.9
ICD-10 Finland
Rosacea, unspecified
4.0
17.3
50
130
R03BA01
ATC
beclometasone; inhalant
2.1
17.2
174
883
J01FA09
ATC
clarithromycin; systemic
1.7
17.1
397
2645
J01DA06
ATC
[U] cefuroxime
2.1
16.9
188
988
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.4
16.9
127
570
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
16.8
344
2210
J45.8
ICD-10 Finland
Mixed asthma
3.7
16.7
53
147
UJF32
NOMESCO Finland
Coloscopy
1.8
16.6
314
1970
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
6.2
16.4
28
46
F01
ICPC
Eye pain
3.5
16.3
56
164
J01MA02
ATC
ciprofloxacin; systemic
1.7
16.3
444
3081
J01DA01
ATC
[U] cefalexin
1.7
16.3
740
5858
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.2
16.2
65
210
R06.0
ICD-10 Finland
Dyspnoea
1.8
16.2
334
2145
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
15.6
16.2
26
17
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
16.2
296
1835
S29
ICPC
Skin symptom/complaint other
1.9
16.2
265
1588
R01AC02
ATC
levocabastine; nasal
4.3
16.1
42
101
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
16.1
338
2182
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
16.1
138
655
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.3
16.1
128
589
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
16.0
390
2626
D02AX
ATC
Other emollients and protectives
3.2
15.8
62
198
E000006, ,
ATC
2.6
15.7
97
397
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
7.3
15.7
23
32
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
15.7
196
1074
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
15.6
182
973
R05
ICD-10 Finland
Cough
1.8
15.5
291
1817
J01FF01
ATC
clindamycin; systemic
1.7
15.4
325
2096
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
15.4
279
1721
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
15.4
150
749
R96
ICPC
Asthma
2.2
15.3
135
648
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
15.1
349
2307
H15.1
ICD-10 Finland
Episcleritis
5.2
15.1
31
61
R53
ICD-10 Finland
Malaise and fatigue
1.7
15.1
319
2059
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.0
15.0
167
876
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.0
15.0
169
892
J01CA04
ATC
amoxicillin; systemic
1.9
14.9
1023
8939
J01AA07
ATC
tetracycline; systemic
1.9
14.7
200
1125
D02AE01
ATC
carbamide; topical
2.6
14.5
87
351
N06AB04
ATC
citalopram; systemic
1.8
14.3
253
1546
F73
ICPC
Eye infection/inflammation other
4.0
14.3
41
106
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
14.3
356
2398
H11.0
ICD-10 Finland
Pterygium
43.0
14.1
17
*
F45.8
ICD-10 Finland
Other somatoform disorders
2.4
13.9
102
452
Z58.8
ICD-10 Finland
Other problems related to physical environment
30.4
13.9
18
6
J02AC02
ATC
itraconazole; systemic
1.8
13.9
220
1300
R21
ICPC
Throat symptom/complaint
1.7
13.8
296
1912
R03BB04
ATC
tiotropium bromide; inhalant
2.2
13.6
117
555
N06AX16
ATC
venlafaxine; oral
1.9
13.6
193
1100
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
13.6
251
1552
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
13.5
172
945
L04AA06
ATC
mycophenolic acid; systemic
4.2
13.5
36
88
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
3.1
13.5
58
196
D06
ICPC
Abdominal pain localized other
2.2
13.4
122
593
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
13.3
242
1488
L04AX01
ATC
azathioprine; systemic
2.8
13.2
65
237
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
13.2
172
954
CBB30
NOMESCO Finland
Excision of lesion of eyelid
3.3
13.1
49
152
R03BB01
ATC
ipratropium bromide; inhalant
3.3
13.1
49
152
N06AX21
ATC
duloxetine; oral
2.0
13.1
164
897
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
13.0
647
5115
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.4
12.9
88
377
D11AH02
ATC
pimecrolimus; topical
22.8
12.9
18
8
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
12.8
125
623
D07XC01
ATC
betamethasone; topical
2.0
12.7
146
774
M03BC51
ATC
orphenadrine, combinations; systemic
1.7
12.7
329
2228
H00.1
ICD-10 Finland
Chalazion
2.9
12.6
61
220
A01
ICPC
Pain general/multiple sites
2.1
12.6
135
697
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.4
12.5
44
131
D01
ICPC
Abdominal pain/cramps general
1.9
12.5
176
999
ZXC60
NOMESCO Finland
Application of heat
4.5
12.4
30
68
D19
ICPC
Teeth/gum symptom/complaint
1.6
12.3
400
2858
N06AX11
ATC
mirtazapine; oral
1.6
12.3
411
2956
S01AA02
ATC
chlortetracycline; ophthalmic
14.5
12.3
20
14
A02BC01
ATC
omeprazole; systemic
1.7
12.2
306
2051
J01DC02
ATC
cefuroxime; systemic
2.5
12.2
75
307
R03BA08
ATC
ciclesonide; inhalant
2.1
12.1
115
568
K07.60
ICD-10 Finland
Snapping jaw
2.4
12.1
81
345
A97
ICPC
No disease
1.7
12.1
259
1666
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
12.0
406
2924
R4120
NOMESCO Finland
Occupational therapy
2.3
12.0
91
410
D06BX01
ATC
metronidazole; topical
2.0
12.0
141
754
R74
ICPC
Upper respiratory infection acute
1.6
11.9
436
3199
S01EE05
ATC
tafluprost; ophthalmic
3.0
11.8
52
178
L01
ICPC
Neck symptom/complaint
1.8
11.8
213
1305
R03BC03
ATC
nedocromil; inhalant
2.4
11.7
85
375
K59.1
ICD-10 Finland
Functional diarrhoea
2.4
11.7
85
375
P01AB01
ATC
metronidazole; oral, rectal
1.5
11.7
484
3645
A07AA02
ATC
nystatin; oral
2.5
11.6
77
326
A01AB04
ATC
amphotericin B; local oral
2.7
11.6
62
236
H16.8
ICD-10 Finland
Other keratitis
23.1
11.6
16
7
L03
ICPC
Low back symptom/complaint
1.6
11.6
364
2575
L17
ICPC
Foot/toe symptom/complaint
1.6
11.6
378
2698
J05AB01
ATC
aciclovir; systemic
1.7
11.5
274
1809
L12
ICPC
Hand/finger symptom/complaint
1.7
11.4
225
1411
R03AC13
ATC
formoterol; inhalant
2.6
11.4
65
256
H02.4
ICD-10 Finland
Ptosis of eyelid
3.2
11.3
45
145
J01FA01
ATC
erythromycin; systemic
1.8
11.2
166
958
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.2
11.2
102
496
S01EA05
ATC
brimonidine; ophthalmic
3.9
11.1
32
83
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
11.1
125
657
H10.8
ICD-10 Finland
Other conjunctivitis
8.1
11.1
24
30
F13
ICPC
Eye sensation abnormal
3.1
11.0
47
158
CG2T4
NOMESCO Finland
Topography assessment of cornea
5.8
11.0
20
35
N05CF01
ATC
zopiclone; oral
1.6
11.0
362
2584
CF2S4
NOMESCO Finland
Photography of conjunctiva
43.7
10.9
13
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.0
10.9
49
170
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
5.5
10.9
21
39
A02BC03
ATC
lansoprazole; oral
1.6
10.8
323
2251
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
10.8
123
649
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
10.8
224
1424
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
10.7
127
680
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
10.7
393
2870
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
10.7
114
588
A02BA02
ATC
ranitidine; systemic
1.7
10.6
213
1342
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
10.6
654
5320
H01.1
ICD-10 Finland
Noninfectious dermatoses of eyelid
11.3
10.6
19
17
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
10.6
173
1028
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.8
10.5
157
906
M54.5
ICD-10 Finland
Low back pain
1.5
10.5
439
3294
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.6
10.5
62
249
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.9
10.4
136
752
H16.4
ICD-10 Finland
Corneal neovascularization
110.9
10.4
11
*
R49.03
ICD-10 Finland
Atrophic dysphonia
5.5
10.4
20
37
R50.9
ICD-10 Finland
Fever, unspecified
1.7
10.4
190
1165
E000003, ,
ATC
2.6
10.4
59
232
L28
ICPC
Limited function/disability (L)
1.7
10.4
208
1310
E000007, ,
ATC
2.4
10.3
71
306
R03AC12
ATC
salmeterol; inhalant
2.7
10.2
54
205
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.3
10.2
76
340
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
10.2
65
271
Z01.7
ICD-10 Finland
Laboratory examination
1.7
10.1
207
1309
G47.3
ICD-10 Finland
Sleep apnoea
1.6
10.1
260
1745
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
10.1
290
1999
R02
ICPC
Shortness of breath/dyspnoea
1.8
10.1
158
926
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
10.1
265
1788
S01BA07
ATC
fluorometholone; ophthalmic
4.5
10.0
24
54
A11
ICPC
Chest pain NOS
2.0
10.0
105
539
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
9.9
325
2310
R13
ICD-10 Finland
Dysphagia
2.2
9.9
88
424
A92
ICPC
Allergy/allergic reaction NOS
2.9
9.8
47
169
J30.1
ICD-10 Finland
Allergic rhinitis due to pollen
26.2
9.8
13
5
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
9.8
206
1312
R03DA04
ATC
theophylline; systemic, rectal
2.6
9.7
57
228
D11
ICPC
Diarrhoea
1.8
9.6
160
954
L13
ICPC
Hip symptom/complaint
1.6
9.6
229
1506
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.4
9.6
63
266
H01
ICPC
Ear pain/earache
1.8
9.6
165
994
L04AA01
ATC
[U] ciclosporin
4.5
9.6
23
52
CG2S4
NOMESCO Finland
Photography of cornea
11.5
9.6
17
15
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
8.5
9.6
20
24
D18
ICPC
Change in faeces/bowel movements
3.0
9.6
42
144
D10BA01
ATC
isotretinoin; oral
2.2
9.6
85
409
U02
ICPC
Urinary frequency/urgency
1.7
9.5
191
1200
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.2
9.5
83
396
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.1
9.5
26
65
H02.1
ICD-10 Finland
Ectropion of eyelid
7.2
9.5
22
31
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
9.5
121
664
S01AA13
ATC
fusidic acid; ophthalmic
3.0
9.5
42
145
R03AK08
ATC
formoterol and beclometasone; inhalant
2.4
9.4
65
281
R01AD11
ATC
triamcinolone; nasal
2.0
9.4
106
558
CGE55
NOMESCO Finland
Excision of pterygium with transplanation of conjunctiva
+∞
9.4
9
*
M01AH01
ATC
celecoxib; oral
1.7
9.4
202
1294
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
21.9
9.4
13
6
S01AA12
ATC
tobramycin; ophthalmic
21.9
9.4
13
6
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
2.1
9.3
85
413
L04AX03
ATC
methotrexate; systemic
1.9
9.3
124
690
R35
ICD-10 Finland
Polyuria
2.2
9.3
77
360
A04
ICPC
Weakness/tiredness general
1.7
9.3
189
1192
N03AX12
ATC
[U] gabapentin; oral
1.7
9.3
184
1153
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.0
9.3
100
518
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
7.3
9.2
21
29
N02BE01
ATC
paracetamol; systemic, rectal
1.7
9.2
1056
9638
A01AB09
ATC
miconazole; local oral
2.0
9.2
103
541
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
9.1
53
211
R51.80
ICD-10 Finland
Headache
1.7
9.1
198
1270
S21
ICPC
Skin texture symptom/complaint
1.7
9.1
182
1142
S01EC03
ATC
dorzolamide; ophthalmic
5.1
9.1
19
38
M48.0
ICD-10 Finland
Spinal stenosis
1.8
9.1
135
778
J02AB02
ATC
ketoconazole; oral
2.9
9.1
41
143
L04
ICPC
Chest symptom/complaint
2.1
9.1
89
445
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
9.1
77
364
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.3
9.0
67
299
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
9.0
126
712
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
37.0
9.0
11
*
R06.5
ICD-10 Finland
Mouth breathing
2.0
9.0
107
573
R07.0
ICD-10 Finland
Pain in throat
2.0
9.0
93
474
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
7.5
8.9
20
27
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
18.8
8.9
13
7
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
8.9
89
448
K59.0
ICD-10 Finland
Constipation
2.2
8.9
71
327
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.5
8.9
55
226
R01AC01
ATC
cromoglicic acid; nasal
2.8
8.9
43
156
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
8.9
169
1047
R05
ICPC
Cough
1.5
8.9
305
2182
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
8.9
92
470
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.8
8.8
42
151
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.3
8.8
67
303
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.6
8.7
51
204
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.5
8.7
52
210
H02.3
ICD-10 Finland
Blepharochalasis
2.1
8.7
80
390
S01ED51
ATC
timolol, combinations; ophthalmic
2.1
8.7
85
425
114
Kela drug reimbursment
Glaucoma
2.0
8.7
90
460
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
8.7
862
7553
R06AX18
ATC
acrivastine; oral
3.1
8.6
36
120
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.2
8.6
75
358
K04
ICPC
Palpitations/awareness of heart
2.2
8.6
76
365
H26.4
ICD-10 Finland
After-cataract
1.9
8.6
104
561
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
8.6
438
3390
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
2.5
8.6
53
218
A46
ICD-10 Finland
Erysipelas
1.7
8.6
153
931
R06AX11
ATC
astemizole; oral
3.0
8.6
37
126
U13
ICPC
Bladder symptom/complaint other
2.8
8.6
41
148
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
8.5
483
3809
CD2S4
NOMESCO Finland
Photography of eye
10.1
8.5
16
16
U07
ICPC
Urine symptom/complaint other
1.9
8.4
102
550
N02BF01
ATC
gabapentin; oral
1.8
8.4
126
728
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
8.4
286
2039
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.4
8.4
30
91
L02
ICPC
Back symptom/complaint
1.8
8.3
133
783
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
8.3
75
363
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
8.3
154
946
R83
ICPC
Respiratory infection other
1.5
8.3
317
2315
R51.81
ICD-10 Finland
Facial pain NOS
2.9
8.2
37
129
K30
ICD-10 Finland
Functional dyspepsia
1.8
8.2
138
825
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
8.2
285
2039
EB1SA, ,
SPAT
2.2
8.2
70
332
R06AX12
ATC
terfenadine; oral
2.4
8.2
54
229
Z50.1
ICD-10 Finland
Other physical therapy
2.2
8.2
64
293
S01EE04
ATC
travoprost; ophthalmic
3.6
8.2
26
73
P01BA02
ATC
hydroxychloroquine; oral
1.9
8.1
100
542
D07CC01
ATC
betamethasone and antibiotics; topical
1.7
8.1
146
889
M01AG02
ATC
tolfenamic acid; oral, rectal
1.7
8.1
176
1127
A03CA02
ATC
clidinium and psycholeptics; oral
2.3
8.1
61
274
K59.09
ICD-10 Finland
Constipation, unspecified
2.0
8.1
84
429
D06AX01
ATC
fusidic acid; topical
1.9
8.1
107
594
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
8.1
118
676
S01CA03
ATC
hydrocortisone and antiinfectives; ophthalmic
6.9
8.1
19
28
N05BA04
ATC
oxazepam; oral
1.5
8.1
296
2142
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
8.0
242
1677
M02AA07
ATC
piroxicam; topical
1.5
8.0
384
2928
R52.9
ICD-10 Finland
Pain, unspecified
1.8
8.0
123
717
L01BA01
ATC
methotrexate; systemic
2.6
7.9
46
184
H20.1
ICD-10 Finland
Chronic iridocyclitis
4.7
7.9
18
39
M01AH05
ATC
etoricoxib; oral
1.4
7.9
718
6132
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.8
7.9
130
773
J20
ICD-10 Finland
Acute bronchitis
1.8
7.9
125
735
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
7.9
184
1202
A02BA03
ATC
famotidine; systemic
2.6
7.8
43
167
H26.2
ICD-10 Finland
Complicated cataract
4.1
7.8
21
52
M50.3
ICD-10 Finland
Other cervical disc degeneration
3.0
7.8
33
111
S18
ICPC
Laceration/cut
1.4
7.8
528
4281
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
7.7
106
596
S01AX12
ATC
[U] norfloxacin
15.1
7.7
12
8
F71
ICPC
Conjunctivitis allergic
15.1
7.7
12
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
7.7
154
966
R05FB02
ATC
cough suppressants and expectorants; systemic
1.4
7.7
397
3067
L05
ICPC
Flank/axilla symptom/complaint
2.0
7.7
82
424
R07.3
ICD-10 Finland
Other chest pain
1.8
7.6
124
734
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.1
7.6
69
335
D11AX15
ATC
[U] pimecrolimus
18.5
7.6
11
6
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
7.6
333
2493
A29
ICPC
General symptom/complaint other
1.7
7.6
151
946
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
6.2
7.6
19
31
J01
ICD-10 Finland
Acute sinusitis
2.1
7.5
72
357
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.7
7.5
134
815
R49.01
ICD-10 Finland
Functional dysphonia
2.6
7.5
41
159
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
4.3
7.5
19
45
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
4.3
7.5
19
45
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.5
7.5
46
189
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.0
7.4
32
109
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.0
7.4
84
444
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
7.3
85
452
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.5
7.3
46
191
L71
ICD-10 Finland
Rosacea
2.7
7.3
37
138
H04.1
ICD-10 Finland
Other disorders of lacrimal gland
+∞
7.3
7
*
H03.1*B08.1
ICD-10 Finland
Involvement of eyelid in molluscum contagiosum
+∞
7.3
7
*
A01AC01
ATC
triamcinolone; local oral
4.2
7.3
19
46
M79.7
ICD-10 Finland
Fibromyalgia
2.4
7.3
48
204
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
7.2
162
1046
B07.9
ICD-10 Finland
Verruca simplex
2.4
7.2
48
205
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
7.2
126
763
G01AA10
ATC
clindamycin; vaginal
1.6
7.2
174
1146
U01
ICPC
Dysuria/painful urination
1.8
7.2
101
573
H53.1
ICD-10 Finland
Subjective visual disturbances
1.9
7.2
85
456
L50.9
ICD-10 Finland
Urticaria, unspecified
2.3
7.1
54
244
N03AE01
ATC
clonazepam; systemic
2.1
7.1
65
317
M79.1
ICD-10 Finland
Myalgia
1.6
7.1
179
1189
D12
ICPC
Constipation
2.4
7.1
47
200
X58
ICD-10 Finland
Exposure to other specified factors
1.6
7.1
173
1140
R30.0
ICD-10 Finland
Dysuria
2.2
7.1
56
258
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
7.1
137
852
R12
ICD-10 Finland
Heartburn
1.8
7.1
102
583
CBN99
NOMESCO Finland
Other operation on eyelid for malposition
8.8
7.1
14
16
M54
ICD-10 Finland
Dorsalgia
1.7
7.0
146
925
D07CB01
ATC
triamcinolone and antibiotics; topical
3.3
7.0
26
81
H40.9
ICD-10 Finland
Glaucoma, unspecified
3.3
7.0
25
76
Z2446
NOMESCO Finland
Social worker
1.9
7.0
86
467
KMAK, ,
NOMESCO Finland
1.4
6.9
577
4811
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.9
532
4379
N30.0
ICD-10 Finland
Acute cystitis
1.5
6.9
200
1371
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.5
6.9
41
166
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
6.9
209
1448
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
6.9
110
648
K02.0
ICD-10 Finland
Caries limited to enamel
1.5
6.9
257
1860
K13.78
ICD-10 Finland
Other change in the oral mucosa
2.7
6.9
35
131
R52.2
ICD-10 Finland
Other chronic pain
2.3
6.9
49
216
R29
ICPC
Respiratory symptom/complaint other
1.9
6.9
81
434
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.2
6.8
55
255
S01EX03, ,
ATC
4.1
6.8
18
44
H40.0
ICD-10 Finland
Glaucoma suspect
1.9
6.8
85
464
H00.00
ICD-10 Finland
Hordeolum
2.2
6.8
57
269
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.7
6.8
35
132
H92.0
ICD-10 Finland
Otalgia
1.9
6.8
81
436
CFD10
NOMESCO Finland
Repair of conjunctiva
40.3
6.8
8
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.7
293
2183
S01EE01
ATC
latanoprost; ophthalmic
2.1
6.7
60
290
UJH02
NOMESCO Finland
Anoscopy
2.3
6.7
49
218
H01.9
ICD-10 Finland
Inflammation of eyelid, unspecified
3.3
6.7
24
73
P06
ICPC
Sleep disturbance
1.6
6.7
153
992
S01EC04
ATC
brinzolamide; ophthalmic
2.4
6.7
44
187
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.7
6.7
132
825
L82
ICD-10 Finland
Seborrhoeic keratosis
1.5
6.7
210
1466
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
6.7
57
271
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.6
6.7
36
139
X14
ICPC
Vaginal discharge
2.9
6.7
30
105
R60.9
ICD-10 Finland
Oedema, unspecified
2.1
6.7
62
305
ENC30
NOMESCO Finland
Plastic operation of pharynx
4.0
6.6
18
45
Z94.7
ICD-10 Finland
Corneal transplant status
12.3
6.6
11
9
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
12.3
6.6
11
9
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.6
771
6767
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.8
6.6
92
521
M01AB55
ATC
diclofenac, combinations; oral
2.0
6.6
70
362
WX140
NOMESCO Finland
Parabulbar anesthesy
2.3
6.6
50
227
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
6.5
335
2571
HA1RA, ,
SPAT
2.1
6.5
59
287
C05AA08
ATC
fluocortolone; rectal, topical
1.6
6.5
142
910
H93.1
ICD-10 Finland
Tinnitus
1.9
6.5
79
427
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
6.5
242
1748
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
6.5
156
1024
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
6.5
141
903
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
6.5
66
336
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
5.7
6.5
17
30
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
6.4
210
1478
GD1AA, ,
SPAT
1.5
6.4
189
1301
EMB10
NOMESCO Finland
Tonsillectomy
2.1
6.4
62
310
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
4.1
6.4
17
42
EB1AA, ,
SPAT
1.9
6.3
79
431
WX892
NOMESCO Finland
Monitored bed care
1.9
6.3
82
453
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
8.2
6.3
13
16
C07AA05
ATC
propranolol; systemic
1.5
6.3
236
1705
HA1AE, ,
SPAT
2.3
6.3
47
211
R00.2
ICD-10 Finland
Palpitations
1.8
6.3
100
588
L29
ICD-10 Finland
Pruritus
3.5
6.3
21
61
H17.8
ICD-10 Finland
Other corneal scars and opacities
11.1
6.3
11
10
UKC02
NOMESCO Finland
Cystoscopy
1.6
6.3
139
894
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.9
6.3
29
103
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
6.3
122
759
M01AC06
ATC
meloxicam; systemic, rectal
1.4
6.3
390
3089
M05BA04
ATC
alendronic acid; oral
1.8
6.3
94
544
DHB50
NOMESCO Finland
Turbinoplasty
2.6
6.2
34
132
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.9
6.2
28
98
120
Kela drug reimbursment
Hypogammaglobulinaemia
26.8
6.2
8
*
N05BA01
ATC
diazepam; systemic, rectal
1.6
6.2
141
913
SBB10
NOMESCO Finland
Dental impressions
1.8
6.2
95
553
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.9
6.2
73
391
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.7
6.2
110
668
J01MA06
ATC
norfloxacin; oral
1.6
6.2
138
890
SDA03
NOMESCO Finland
Periodontal treatment
1.4
6.2
470
3844
ZXD05
NOMESCO Finland
Urgent procedure
1.4
6.2
319
2448
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
6.2
93
539
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
6.1
209
1483
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
6.1
119
741
G43.9
ICD-10 Finland
Migraine, unspecified
1.9
6.1
76
415
49300
ICD-8 Finland
Asthma, bronchiale
3.1
6.1
25
83
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
6.1
75
408
N05AH04
ATC
quetiapine; oral
1.5
6.1
194
1357
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
12.6
6.1
10
8
D11AH05
ATC
dupilumab; topical
12.6
6.1
10
8
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
6.1
387
3075
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.1
468
3833
AA1AD
NOMESCO Finland
CT of head and brain
1.4
6.0
287
2169
R03DC01
ATC
zafirlukast; oral
3.4
6.0
21
63
H26.3
ICD-10 Finland
Drug-induced cataract
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
341
1780
2.27
33.26
3.5
3.0
0.73
1.13
e6/l
2.10
168
945
450
2679
2.08
30.98
4.5
4.2
93.84
91.53
%
1.17
443
2617
838
6294
2.05
29.21
11.4
10.0
3.94
3.99
e9/l
0.24
730
5490
358
2027
2.08
27.65
2.8
2.8
2.44
2.45
mmol/l
0.89
302
1837
656
4624
1.90
26.36
5.3
5.1
36.60
36.01
g/l
2.25
617
4362
513
3353
1.91
25.87
4.3
3.4
48.13
63.48
e6/l
0.26
383
2561
460
2905
1.94
25.69
4.3
3.3
0.22
0.41
e6/l
3.10
327
2132
398
2403
1.97
25.31
1.6
1.5
2.22
2.31
g/l
0.46
234
1486
180
795
2.48
25.11
1.6
1.3
399.63
207.19
u/ml
1.07
170
736
545
3704
1.85
23.74
3.7
3.4
2.36
2.36
mmol/l
0.10
489
3384
971
7957
2.07
23.19
5.7
4.4
10.81
11.67
mm/h
1.27
936
7456
294
1639
2.04
23.12
3.6
3.1
2.79
3.14
e6/l
0.14
120
811
176
809
2.37
22.36
1.9
1.5
—
—
—
0
0
118
447
2.81
22.33
1.3
1.3
0.24
1.28
u/ml
—
9
32
622
4531
1.76
20.44
2.4
2.0
97.88
96.94
pmol/l
0.19
330
2364
652
4818
1.76
20.33
8.0
6.9
1.21
1.22
mmol/l
0.17
626
4471
697
5302
1.73
19.12
3.4
3.0
114.23
108.29
ug/l
0.18
670
4974
856
6950
1.77
18.11
6.4
4.6
424.77
2374.52
e6/l
1.46
13
94
466
3216
1.73
17.85
2.5
2.1
139.67
216.55
u/l
1.65
442
3061
648
4897
1.69
17.62
10.9
11.3
0.00
0.00
e9/l
0.38
516
4022
71
234
3.16
17.17
1.1
1.1
4.69
5.18
u/ml
0.13
56
131
663
5065
1.67
17.09
3.0
2.6
79.53
77.01
nmol/l
1.49
619
4619
959
8134
1.83
16.53
9.3
8.0
80.46
80.39
u/l
0.01
928
7735
395
2651
1.72
16.45
2.7
2.7
326.34
328.75
umol/l
0.18
356
2356
186
1002
2.01
15.59
2.9
2.4
104.82
40.58
u/l
0.42
164
836
109
478
2.41
15.24
1.8
1.9
6.37
8.32
iu/ml
0.43
29
110
168
881
2.05
15.15
3.4
3.0
9.75
10.54
g/l
2.04
161
817
685
5374
1.62
15.11
8.6
7.4
1.22
1.22
mmol/l
0.03
633
4663
35
77
4.65
15.00
1.3
1.4
27.20
19.00
u/ml
—
5
12
331
2167
1.72
14.82
1.5
1.3
26.56
30.73
iu/ml
0.30
99
671
346
2314
1.69
14.23
3.4
2.7
4.65
6.71
e6/l
2.95
319
2101
402
2800
1.65
14.12
1.5
1.4
2.11
1.69
u/ml
0.21
102
775
397
2758
1.65
14.08
2.4
2.3
2.52
2.85
mg/l
2.73
356
2391
65
229
2.94
14.03
1.1
1.1
3.11
2.07
u/ml
0.28
46
112
134
665
2.14
13.94
1.4
1.3
22.97
39.85
au/ml
—
6
53
252
1553
1.78
13.84
2.7
2.5
128.05
124.18
ug/g
0.05
197
1240
143
731
2.08
13.77
2.6
2.4
29.21
20.94
au/ml
0.33
17
80
71
275
2.68
12.86
1.2
1.1
2.44
3.33
u/ml
0.18
50
162
1021
9036
1.79
12.65
27.4
19.1
332.38
332.29
g/l
0.12
1016
8982
714
5793
1.56
12.60
5.2
4.0
0.05
0.02
estimate
0.30
86
1126
62
226
2.84
12.60
1.1
1.1
4.21
1.38
u/ml
0.91
43
132
79
326
2.52
12.59
1.3
1.2
3.75
2.53
u/ml
—
8
29
982
8604
1.72
12.52
5.6
4.5
14.67
14.72
pmol/l
0.26
930
7953
44
133
3.39
12.26
1.1
1.2
—
—
—
0
0
92
413
2.33
12.20
1.8
1.7
—
—
—
0
0
1096
9945
1.98
12.14
7.1
5.5
1.80
1.90
mu/l
2.79
1045
9271
78
327
2.48
12.03
1.3
1.2
10.09
6.59
u/ml
—
10
49
135
711
2.01
11.95
1.9
1.8
1.05
1.29
g/l
1.90
125
660
698
5677
1.53
11.86
5.1
3.9
0.00
0.00
estimate
0.50
89
1171
373
2643
1.59
11.81
2.4
2.3
—
—
—
0
0
352
2461
1.60
11.79
1.9
1.8
0.95
1.26
mg/l
1.35
293
1905
99
467
2.22
11.68
2.4
2.2
40.40
39.31
u/l
0.25
91
415
55
196
2.89
11.66
1.3
1.4
—
—
—
0
0
55
196
2.89
11.66
1.3
1.4
—
—
—
0
0
1142
10549
2.25
11.57
20.9
14.7
21.83
22.55
mg/l
0.33
967
8528
297
2003
1.64
11.48
1.4
1.3
5.65
13.44
u/ml
1.81
94
785
146
803
1.93
11.40
2.5
2.1
—
—
—
0
0
701
5747
1.51
11.17
5.1
3.9
18.04
2.63
estimate
0.40
90
1201
80
352
2.36
11.11
1.6
1.3
—
—
—
0
0
46
157
3.01
10.54
1.5
1.5
—
—
—
0
0
1002
8978
1.64
9.97
24.0
18.4
13.52
13.55
%
0.32
993
8860
124
677
1.93
9.88
2.3
1.9
—
—
—
0
0
823
7095
1.49
9.41
3.7
3.2
—
—
—
0
0
259
1767
1.59
9.34
2.2
2.5
14.37
13.20
umol/l
1.69
246
1650
316
2260
1.54
9.24
1.9
1.6
—
—
—
0
0
1142
10673
2.06
9.20
22.8
17.2
3.93
3.96
mmol/l
2.26
1117
10453
1083
9960
1.76
9.10
18.1
14.0
83.87
83.32
ml/min/173m2
0.38
1002
9154
392
2942
1.49
9.09
1.8
1.6
22.44
20.65
nmol/l
1.51
351
2492
1139
10649
2.01
8.95
22.6
17.1
139.59
139.67
mmol/l
0.46
1119
10449
72
334
2.23
8.88
2.1
2.2
9.70
10.74
g/l
1.59
67
300
676
5648
1.44
8.82
6.3
6.5
11.16
11.44
umol/l
0.22
656
5394
24
63
3.87
8.26
2.1
3.6
885.79
849.33
u/ml
0.04
24
63
190
1242
1.63
8.10
2.7
3.2
6.20
8.00
umol/l
1.11
171
1085
273
1943
1.52
8.03
4.1
3.7
939.85
512.11
ng/l
0.23
203
1420
65
302
2.22
8.00
1.2
1.2
—
—
—
0
0
50
211
2.43
7.68
1.6
1.6
—
—
—
0
0
64
301
2.19
7.66
1.3
1.2
—
—
—
0
0
21
54
3.94
7.45
1.1
1.1
—
—
—
0
0
203
1386
1.56
7.16
2.3
2.2
—
—
—
0
0
102
582
1.82
7.10
1.9
1.6
—
—
—
0
0
251
1806
1.49
6.92
4.1
4.0
0.82
0.82
mmol/l
0.03
240
1708
125
763
1.71
6.91
2.0
1.6
—
—
—
0
0
215
1501
1.52
6.84
2.4
2.5
24.56
22.54
%
1.29
207
1412
181
1217
1.57
6.82
2.1
1.8
—
—
—
0
0
129
802
1.68
6.66
2.8
2.3
3.94
7.77
ug/l
4.80
110
716
27
90
3.05
6.52
1.3
1.2
—
—
—
0
0
226
1614
1.49
6.43
1.7
1.7
1170.65
1204.01
nmol/l
0.24
183
1224
27
91
3.01
6.41
1.0
1.3
1.72
1.70
u/ml
0.00
19
43
25
81
3.13
6.34
1.2
1.2
—
—
—
0
0
62
312
2.04
6.28
2.6
3.9
54.67
66.98
mg/l
0.23
54
266
62
312
2.04
6.28
2.6
3.9
25.58
53.87
mg/l
1.51
54
267
184
1267
1.53
6.21
2.2
2.1
—
—
—
0
0
333
2574
1.40
6.18
5.5
4.0
1.02
1.02
kg/l
0.58
244
1710
22
67
3.33
6.15
1.2
1.2
—
—
—
0
0
25
83
3.05
6.09
1.2
1.2
—
—
—
0
0
25
83
3.05
6.09
1.2
1.2
—
—
—
0
0
168
1139
1.55
6.08
2.7
2.1
371.83
376.12
nmol/l
0.10
156
1064
226
1631
1.47
6.08
2.3
2.4
2.40
2.37
g/l
0.34
218
1518
1161
11089
1.93
6.07
15.4
11.7
26.46
25.86
u/l
0.42
1140
10797
16
29
5.58
6.00
1.1
1.0
—
—
—
0
0
222
1602
1.47
5.97
2.2
2.3
28.53
29.43
s
2.40
212
1560
28
102
2.79
5.82
1.2
1.2
—
—
—
0
0
455
3734
1.35
5.74
3.0
3.5
31.10
31.84
u/l
0.13
435
3532
107
659
1.68
5.74
8.4
10.9
94.73
94.15
%
0.52
107
654
130
843
1.61
5.70
3.9
4.3
71.51
79.73
ng/l
0.91
121
746
60
310
1.98
5.68
2.6
2.8
—
—
—
0
0
181
1269
1.50
5.60
2.1
1.8
—
—
—
0
0
24
82
2.97
5.59
1.3
1.2
—
—
—
0
0
15
28
5.41
5.54
1.3
1.1
71.93
92.00
%
1.60
15
28
169
1171
1.51
5.53
8.2
6.5
—
—
—
0
0
1164
11164
1.88
5.45
25.2
18.8
74.23
73.09
umol/l
0.51
1151
11043
710
6253
1.32
5.36
5.9
5.2
6.44
6.63
mmol/l
1.81
675
5898
25
91
2.78
5.22
1.2
1.0
—
—
—
0
0
39
177
2.24
5.17
1.1
1.1
3.31
6.49
u/ml
0.82
22
80
54
279
1.98
5.13
2.7
3.7
6.38
3.19
ratio
0.56
32
157
55
290
1.94
4.94
3.8
3.3
3.17
2.68
index
0.21
36
164
367
2972
1.34
4.91
3.2
3.2
1032.54
1058.17
ng/l
0.04
316
2501
101
643
1.62
4.79
1.1
1.1
—
—
—
0
0
32
138
2.35
4.78
1.3
1.2
—
—
—
0
0
64
361
1.82
4.70
1.7
1.5
0.74
0.06
iu/ml
0.42
12
64
256
1981
1.37
4.57
1.5
1.5
—
—
—
0
0
10
15
6.71
4.47
1.1
1.1
0.13
0.07
u/ml
—
10
15
811
7364
1.30
4.45
3.5
3.4
44.72
44.98
u/l
0.03
779
6958
26
108
2.44
4.24
1.2
1.1
—
58.29
—
0
7
56
315
1.82
4.18
1.4
1.4
304.32
293.72
ug/g
0.12
36
189
220
1689
1.37
4.11
2.3
1.9
—
—
—
0
0
89
576
1.59
3.98
1.3
1.4
—
—
—
0
0
34
164
2.10
3.95
1.1
1.1
0.21
0.35
u/ml
0.30
15
63
1188
11561
1.96
3.91
31.0
22.6
257.75
256.43
e9/l
0.28
1168
11344
144
1037
1.44
3.89
2.7
4.3
10.93
24.72
ug/l
0.72
111
845
69
422
1.67
3.87
1.7
1.7
13.14
11.29
u/ml
0.14
17
99
195
1483
1.37
3.85
7.5
6.0
1.07
1.06
mmol/l
0.09
186
1378
1188
11566
1.95
3.82
30.9
22.5
91.11
90.67
fl
2.77
1177
11462
1058
10047
1.39
3.82
5.9
4.9
5.80
5.88
mmol/l
1.51
1004
9277
174
1301
1.39
3.81
1.6
1.8
1.48
1.45
%
0.19
152
1156
1188
11569
1.94
3.77
31.0
22.6
6.77
6.69
e9/l
0.42
1166
11310
1188
11569
1.94
3.77
31.0
22.5
4.48
4.49
e12/l
0.28
1163
11317
1188
11569
1.94
3.77
31.8
23.1
40.41
40.25
%
0.55
1177
11461
1188
11575
1.92
3.67
31.2
22.7
134.99
134.77
g/l
0.22
1177
11469
37
190
1.98
3.66
1.1
1.1
5.69
4.51
u/ml
0.15
21
101
122
863
1.46
3.63
1.3
1.2
93.56
123.68
u/ml
0.55
46
343
60
361
1.70
3.59
3.0
3.1
3.42
3.42
g/l
0.00
55
348
23
98
2.37
3.59
1.3
1.1
100.83
108.43
pmol/l
0.40
23
98
58
348
1.70
3.51
2.4
2.2
156.25
418.57
ug/l
1.30
53
330
104
718
1.49
3.50
2.8
3.5
4.29
4.59
pmol/l
2.77
97
636
68
426
1.63
3.50
1.3
1.3
216.84
250.63
miu/ml
0.35
35
201
30
145
2.10
3.49
1.4
1.4
318.44
352.75
pmol/l
0.16
25
126
59
358
1.68
3.44
1.4
1.3
—
—
—
0
0
120
860
1.44
3.35
2.1
2.6
67.37
68.80
ml/min/173m2
0.17
46
378
17
65
2.64
3.31
1.2
2.2
2.08
1.92
umol/l
0.58
17
57
25
115
2.20
3.30
1.5
1.6
—
—
—
0
0
139
1026
1.40
3.29
2.2
2.5
0.22
0.21
g/l
1.19
127
964
153
1148
1.38
3.29
7.3
8.9
13.05
12.55
kpa
0.50
146
1109
153
1148
1.38
3.29
7.3
8.9
5.03
5.10
kpa
0.51
147
1109
515
4532
1.24
3.25
1.9
1.9
1.35
1.36
mmol/l
0.10
455
3869
100
700
1.47
3.16
2.5
3.1
169.30
192.36
ng/l
0.32
88
643
23
105
2.21
3.10
1.3
1.1
—
—
—
0
0
6
8
7.53
3.05
1.8
1.6
—
—
—
0
0
18
74
2.45
3.05
5.5
3.9
0.89
0.84
index
0.11
18
74
150
1136
1.37
3.05
7.4
9.0
1.01
0.87
mmol/l
0.21
125
938
75
499
1.54
3.03
1.5
1.6
0.38
0.31
mg/l
0.26
33
229
51
309
1.68
3.02
1.8
1.3
—
—
—
0
0
9
21
4.31
2.99
1.1
1.1
—
—
—
0
0
445
3891
1.23
2.91
4.4
3.6
51.14
58.95
ng/l
0.10
274
2640
7
13
5.41
2.87
1.7
2.4
—
—
—
0
0
564
5055
1.21
2.87
3.0
2.7
—
—
estimate
—
0
0
41
238
1.75
2.84
9.9
7.7
170.70
342.33
iu/ml
—
10
36
52
323
1.64
2.82
1.3
1.3
—
—
—
0
0
16
66
2.44
2.71
1.4
1.2
—
—
—
0
0
113
835
1.39
2.69
2.1
2.4
0.26
0.52
e6/l
1.12
107
795
17
73
2.35
2.66
1.5
1.6
36.11
26.18
umol/l
0.46
17
66
21
99
2.14
2.65
4.1
4.0
—
—
—
0
0
47
290
1.65
2.63
1.6
1.6
—
—
—
0
0
53
338
1.59
2.61
2.5
1.9
2.93
4.22
iu/l
0.60
22
139
23
114
2.04
2.57
3.3
1.7
—
—
—
0
0
18
81
2.24
2.54
2.2
2.8
507.44
927.90
mg
1.22
18
81
6
11
5.48
2.54
1.3
1.5
—
—
—
0
0
392
3422
1.21
2.54
3.0
2.6
60.09
61.46
u/l
0.18
368
3173
1022
9780
1.27
2.54
7.1
6.1
38.30
39.00
mmol/mol
2.09
977
9222
30
165
1.84
2.50
1.5
1.3
—
—
—
0
0
1069
10301
1.30
2.41
5.4
4.9
1.50
1.49
mmol/l
0.10
1021
9609
94
688
1.40
2.39
1.4
1.5
28.91
26.95
iu/l
0.20
75
581
95
698
1.39
2.36
2.6
2.4
12.24
12.61
nmol/l
0.17
83
640
1084
10478
1.30
2.29
6.5
5.6
2.75
2.76
mmol/l
0.27
1040
9803
25
134
1.88
2.28
3.0
2.6
34.40
31.66
iu/ml
—
5
14
1071
10342
1.29
2.23
5.7
5.0
4.69
4.71
mmol/l
0.33
1030
9711
62
427
1.48
2.20
1.4
1.9
4.07
5.12
mg/l
0.23
51
312
59
403
1.49
2.18
2.6
2.9
95.44
91.26
%
0.91
59
394
42
267
1.59
2.14
2.2
1.7
3.71
3.66
mmol/l
0.17
42
255
13
55
2.38
2.12
1.8
1.9
6.02
4.92
nmol/l
0.08
13
44
46
301
1.55
2.08
2.4
1.7
—
—
—
0
0
24
132
1.83
2.04
3.3
1.6
—
—
—
0
0
17
83
2.06
2.01
2.6
2.1
—
—
—
0
0
11
44
2.51
2.01
1.7
1.2
—
—
—
0
0
11
44
2.51
2.01
1.7
1.2
—
—
—
0
0
37
232
1.61
2.01
1.8
1.6
161.85
145.30
au/ml
0.48
12
78
151
1219
1.27
2.00
1.9
2.0
3.44
3.48
ratio
0.12
118
941
41
264
1.57
2.00
2.0
1.9
460.85
906.08
e6/l
0.34
27
207
28
163
1.73
1.99
1.4
1.4
—
0.53
—
0
12
74
539
1.40
1.98
1.6
1.4
—
—
—
0
0
12
51
2.37
1.95
1.9
1.5
—
—
—
0
0
14
64
2.20
1.94
1.2
1.1
0.99
1.08
u/l
—
7
33
10
39
2.58
1.94
1.2
1.3
8.97
8.41
ug/l
—
10
39
6
16
3.76
1.93
1.7
1.4
—
—
—
0
0
28
165
1.71
1.92
1.3
3.0
4.92
7.41
umol/l
0.72
18
119
7
22
3.19
1.88
1.4
1.5
—
—
—
0
0
1018
9816
1.22
1.87
4.8
4.2
1.34
1.28
mmol/l
1.76
972
9097
43
285
1.53
1.86
1.5
1.5
—
—
—
0
0
27
159
1.71
1.86
1.9
1.4
23.91
24.25
ng/l
0.02
27
159
40
261
1.55
1.86
2.0
1.8
13.76
37.87
e6/l
0.51
25
198
32
198
1.63
1.85
2.6
1.8
—
—
—
0
0
136
1097
1.27
1.82
5.9
4.8
1.66
1.77
mmol/l
0.12
118
929
54
378
1.45
1.81
2.4
3.4
12693.30
3563.91
u/ml
0.32
43
333
30
184
1.65
1.79
1.2
1.2
57.30
19.82
u/l
0.72
24
158
30
184
1.65
1.79
1.5
1.2
—
—
—
0
0
21
116
1.82
1.79
4.0
4.9
17.84
85.82
u/ml
—
8
37
43
289
1.51
1.76
1.5
1.5
0.94
0.95
ratio
0.06
29
185
43
289
1.51
1.76
1.5
1.5
1.37
1.15
ratio
0.52
29
185
43
289
1.51
1.76
1.5
1.5
1.04
1.23
ratio
1.03
29
185
24
139
1.74
1.76
1.2
1.2
—
—
—
0
0
12
54
2.23
1.74
1.3
1.2
—
—
—
0
0
7
24
2.93
1.72
1.4
1.4
0.43
0.41
ug/l
—
7
19
479
4377
1.16
1.68
5.0
3.8
0.00
0.04
estimate
4.07
71
985
6
19
3.17
1.66
1.0
1.0
—
—
—
0
0
13
62
2.11
1.66
1.7
1.2
—
—
—
0
0
13
62
2.11
1.66
1.8
1.2
—
—
—
0
0
23
135
1.72
1.63
1.6
1.4
286.78
280.07
mosm/kgh2o
0.90
18
104
25
151
1.67
1.60
1.4
1.7
—
—
—
0
0
39
263
1.50
1.60
1.6
1.3
—
—
—
0
0
10
43
2.34
1.59
1.0
1.0
—
—
—
0
0
24
145
1.67
1.55
1.6
1.8
—
—
—
0
0
8
33
2.43
1.54
1.5
1.2
—
—
—
0
0
5
15
3.34
1.52
3.0
2.4
—
—
—
0
0
7
27
2.60
1.51
1.7
2.3
19.30
15.29
umol/l
—
7
27
17
94
1.82
1.47
3.0
2.8
—
—
—
0
0
87
685
1.29
1.45
5.0
4.8
2.24
1.75
mmol/l
0.41
61
512
9
39
2.32
1.43
2.3
1.5
363.11
62.49
nmol/24h
—
9
39
22
133
1.67
1.43
2.4
1.4
—
—
—
0
0
22
133
1.67
1.43
2.4
1.4
—
—
—
0
0
50
363
1.39
1.42
1.4
1.5
—
—
—
0
0
31
205
1.53
1.41
1.4
1.6
—
—
—
0
0
9
40
2.26
1.40
1.6
1.1
—
—
—
0
0
22
134
1.65
1.39
2.4
1.4
—
—
—
0
0
23
142
1.63
1.39
1.1
1.4
0.15
0.31
nmol/l
0.61
13
110
112
916
1.25
1.38
1.8
1.7
3.63
3.50
mmol/l
0.45
80
645
11
208
0.52
1.33
1.0
1.1
—
113.98
—
0
53
12
61
1.98
1.33
2.6
6.6
—
42.27
—
0
15
71
552
1.30
1.32
5.3
4.0
1.18
1.24
%
0.26
71
547
15
83
1.82
1.31
1.0
1.3
—
—
—
0
0
245
2168
1.16
1.31
1.6
1.7
425.39
38749054.05
pmol/l
2.66
212
1822
21
129
1.64
1.30
2.0
2.5
15.90
24.01
mg/l
—
10
56
45
327
1.39
1.29
2.9
3.9
1.14
1.35
mmol/l
1.79
45
320
16
268
0.59
1.28
1.5
1.6
—
—
—
0
0
5
18
2.78
1.28
1.8
1.3
—
—
—
0
0
9
44
2.05
1.27
1.0
1.2
133.21
203.20
iu/ml
—
9
44
22
138
1.61
1.26
2.5
1.3
—
—
—
0
0
25
163
1.54
1.23
1.1
1.1
0.67
2.73
eliau/ml
—
6
75
16
264
0.60
1.22
1.4
2.9
1.45
1.57
mmol/l
0.39
16
256
5
19
2.64
1.21
1.6
1.3
—
—
—
0
0
16
93
1.73
1.21
1.3
1.4
1771.80
1942.78
e6/l
—
10
60
22
140
1.58
1.20
2.5
1.3
—
—
—
0
0
22
140
1.58
1.20
2.5
1.3
—
—
—
0
0
12
213
0.56
1.20
1.5
3.0
7.50
7.55
mmol/l
0.03
12
206
495
4614
1.12
1.20
15.3
13.2
1.23
1.21
inr
0.36
412
3825
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
64
1.88
1.18
1.3
1.2
—
—
—
0
0
16
94
1.71
1.17
1.7
1.8
—
—
—
0
0
40
291
1.39
1.16
2.5
1.7
—
—
—
0
0
36
257
1.41
1.16
1.4
1.6
—
—
—
0
0
35
249
1.42
1.15
2.0
1.6
9247.87
14631.70
e6/l
0.36
23
181
347
3175
1.13
1.14
6.0
4.0
0.00
0.01
estimate
1.54
82
1118
68
850
0.79
1.12
5.8
3.7
1.22
1.23
mmol/l
0.89
62
726
7
30
2.34
1.12
1.9
1.2
—
—
—
0
0
7
30
2.34
1.12
1.3
1.1
—
—
—
0
0
11
58
1.90
1.12
1.3
1.2
0.57
0.52
ratio
—
5
34
7
31
2.27
1.10
1.9
1.1
—
—
—
0
0
12
66
1.83
1.09
1.3
1.1
55.36
82.69
u/l
1.58
12
61
12
66
1.83
1.09
1.3
1.1
7.24
26.53
u/l
2.94
12
59
7
33
2.13
1.05
1.1
2.2
43.10
41.02
g/l
—
7
33
7
33
2.13
1.05
2.1
1.3
—
—
—
0
0
33
238
1.40
1.03
1.8
1.7
—
—
—
0
0
140
1210
1.18
1.03
3.7
3.0
0.66
0.77
ug/l
0.81
97
730
13
75
1.74
1.03
1.2
1.3
—
—
—
0
0
7
34
2.06
1.03
2.7
2.6
0.64
0.61
mmol/l
—
7
34
18
114
1.59
1.03
9.8
5.5
8.03
6.90
mmol/l
0.37
11
93
14
83
1.69
1.01
1.4
1.4
225522.86
115942.16
e6/l
—
7
44
12
201
0.59
1.00
1.5
1.6
55.43
53.61
ug/l
0.05
12
201
7
35
2.01
1.00
1.0
1.1
23.76
52.10
iu/ml
—
7
35
56
443
1.28
0.97
1.5
1.5
—
—
—
0
0
27
375
0.71
0.95
3.4
1.9
—
—
—
0
0
12
70
1.72
0.92
1.3
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
52
1.74
0.92
1.6
1.7
122.11
135.63
%
—
9
52
8
42
1.91
0.88
1.0
1.5
—
—
—
0
0
10
56
1.79
0.88
1.5
1.3
8.50
8.00
mm/h
—
10
56
25
178
1.41
0.86
1.2
1.1
—
—
—
0
0
8
45
1.78
0.84
1.1
1.0
—
—
—
0
0
6
111
0.54
0.83
2.8
3.6
31.32
76.26
u/ml
—
6
111
25
342
0.73
0.83
2.4
1.8
—
—
—
0
0
30
223
1.35
0.82
1.1
1.1
6.18
20.57
au/ml
—
6
53
55
447
1.24
0.79
1.5
1.7
286.38
296.52
mu/l
0.09
50
411
16
235
0.68
0.79
2.1
1.8
—
—
—
0
0
6
33
1.82
0.79
2.0
1.2
—
—
—
0
0
9
151
0.59
0.78
1.2
1.4
7.30
7.38
mmol/l
—
9
130
11
67
1.65
0.75
1.0
2.2
31.09
30.46
umol/l
0.08
11
61
9
54
1.67
0.74
1.9
1.2
158.62
169.56
pmol/l
—
9
54
5
25
2.00
0.72
1.4
1.2
—
—
—
0
0
7
39
1.80
0.72
1.3
1.1
—
—
—
0
0
10
60
1.67
0.72
1.6
1.6
—
—
—
0
0
10
60
1.67
0.72
1.6
1.7
—
—
—
0
0
16
109
1.47
0.71
1.2
1.2
—
—
—
0
0
10
61
1.64
0.68
1.4
1.6
—
—
—
0
0
7
42
1.67
0.68
1.1
1.2
—
—
—
0
0
14
94
1.50
0.67
1.2
1.2
—
—
—
0
0
108
954
1.14
0.65
10.0
7.8
8.55
8.70
mmol/l
0.09
102
914
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
29
368
0.78
0.61
3.0
3.2
24.62
24.79
mmol/l
0.11
29
361
46
381
1.22
0.60
5.2
5.5
9.30
8.80
kpa
1.34
46
370
0
22
0.00
0.59
0.0
1.9
—
1.18
—
0
22
297
3157
0.92
0.59
3.9
3.3
0.00
0.07
estimate
0.78
72
955
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
303
1.23
0.54
2.4
3.8
0.30
0.36
iu/ml
0.66
15
154
12
83
1.45
0.52
1.3
1.9
—
—
—
0
0
217
2027
1.09
0.50
5.7
5.1
1.87
2.38
ug/l
1.20
197
1831
22
171
1.29
0.50
1.4
1.3
4.22
4.83
u/ml
—
9
78
36
432
0.83
0.49
1.4
1.5
—
—
—
0
0
26
208
1.26
0.48
1.4
1.5
—
—
—
0
0
33
397
0.83
0.47
1.1
1.1
0.64
0.70
ratio
—
6
48
73
648
1.13
0.45
5.4
4.2
126.42
129.31
g/l
0.54
73
631
22
174
1.27
0.45
1.1
1.1
—
—
—
0
0
13
95
1.37
0.43
3.9
1.5
—
—
—
0
0
13
95
1.37
0.43
3.9
1.5
—
—
—
0
0
13
95
1.37
0.43
3.9
1.5
—
—
—
0
0
5
33
1.52
0.41
2.2
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
9.56
—
0
15
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
39
454
0.85
0.40
3.2
3.3
26.12
25.23
mmol/l
1.06
39
437
385
3702
1.06
0.40
3.9
3.4
6.97
7.43
mmol/l
1.25
338
3176
0
18
0.00
0.40
0.0
1.8
—
5.98
—
0
10
172
1611
1.08
0.39
5.1
4.2
23.63
21.50
%
0.80
81
726
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
43
375
1.15
0.36
1.5
1.6
9.00
9.12
u/l
0.03
33
290
16
126
1.27
0.35
1.0
1.1
—
—
—
0
0
22
181
1.22
0.34
3.6
3.3
0.74
0.85
nmol/l
0.51
17
151
37
423
0.87
0.32
1.1
1.1
1.60
1.56
g/l
0.26
37
423
41
465
0.88
0.32
2.0
2.3
3632.50
5759.62
u/l
—
10
202
6
47
1.28
0.32
7.2
1.6
—
—
—
0
0
6
47
1.28
0.32
7.2
1.6
—
—
—
0
0
6
47
1.28
0.32
7.2
1.6
—
—
—
0
0
6
47
1.28
0.32
7.2
1.6
—
—
—
0
0
27
229
1.18
0.32
2.3
2.4
348.07
83.80
ug/min
0.71
12
138
94
1015
0.92
0.31
4.1
3.2
—
—
—
0
0
15
186
0.80
0.31
2.2
1.7
—
—
—
0
0
11
84
1.31
0.30
1.5
1.2
—
—
—
0
0
20
166
1.21
0.30
1.5
1.6
—
—
—
0
0
25
290
0.86
0.27
1.4
1.4
97.20
239.49
pmol/l
1.27
25
284
24
207
1.16
0.25
5.1
3.6
23.36
25.55
mg/l
0.14
16
138
30
265
1.14
0.23
1.8
2.3
139.47
128.54
g/l
0.73
15
217
5
39
1.28
0.23
8.4
1.6
—
—
—
0
0
5
39
1.28
0.23
8.4
1.6
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
5
40
1.25
0.22
1.8
2.2
—
—
—
0
0
5
40
1.25
0.22
8.4
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
0
12
0.00
0.21
0.0
2.4
—
69.24
—
0
12
20
173
1.16
0.21
1.2
1.2
3.50
4.47
u/ml
—
6
62
11
89
1.24
0.21
1.5
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
47
511
0.92
0.20
3.0
3.8
49.99
47.30
%
0.33
47
499
19
164
1.16
0.20
1.1
1.2
122.89
115.28
%
0.71
19
153
0
14
0.00
0.20
0.0
9.1
—
10.46
—
0
14
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
7
61
1.15
0.17
1.3
1.7
—
1020533.17
—
0
6
7
62
1.13
0.17
2.3
1.3
—
—
—
0
0
7
62
1.13
0.17
1.1
1.5
109.56
99.44
ng/l
—
7
62
133
1278
1.05
0.17
5.1
4.7
31.31
32.12
%
0.42
99
873
5
67
0.75
0.17
1.2
1.1
1085.20
1613.39
miu/ml
—
5
67
5
70
0.71
0.16
3.0
1.6
72.40
78.01
umol/l
—
5
70
58
546
1.07
0.15
1.6
1.6
807.68
962.24
mu/l
1.23
48
457
28
255
1.10
0.15
1.7
1.5
213.04
241.42
u/ml
0.23
16
146
10
85
1.18
0.12
1.5
1.2
—
—
—
0
0
33
308
1.07
0.11
1.2
1.3
—
—
—
0
0
5
44
1.14
0.10
1.6
1.2
—
—
—
0
0
14
154
0.91
0.08
1.0
1.1
—
—
—
0
0
7
65
1.08
0.08
2.7
1.9
—
—
—
0
0
20
215
0.93
0.07
2.2
2.6
19.21
16.27
%
3.86
20
209
6
71
0.84
0.07
1.2
1.6
—
—
—
0
0
343
3395
1.01
0.07
4.7
4.2
7.40
8.37
mg/mmol
0.23
196
2090
23
217
1.06
0.06
1.5
1.6
—
—
—
0
0
11
104
1.06
0.01
1.1
1.2
—
—
u/ml
—
0
0
7
71
0.99
0.00
1.9
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
3.17
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
81
0.99
-0.00
1.1
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
-0.00
1.2
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
8.06
—
0
6
6
60
1.00
-0.00
1.2
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_CONJUNCTIVITISCHRON and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUNCTIVITISCHRON | 1.053 [0.93, 1.19] | 0.416 |
| Birth year | 0.995 [0.99, 1.0] | 0.315 |
During the follow-up period (1.1.1998 — 31.12.2019), 451 out of 4367 females with H7_CONJUNCTIVITISCHRON died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUNCTIVITISCHRON | 1.056 [0.9, 1.23] | 0.494 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 290 out of 2698 males with H7_CONJUNCTIVITISCHRON died.
Mortality risk
Mortality risk for people of age
years, who have H7_CONJUNCTIVITISCHRON.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.113% | 0.184% |
| 5 | 0.617% | 1.142% |
| 10 | 1.576% | 2.972% |
| 15 | 2.77% | 5.727% |
| 20 | 5.35% | 9.739% |
Relationships between endpoints
↥Index endpoint: H7_CONJUNCTIVITISCHRON – Chronic conjunctivitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data